Form 4: Neurocrine Biosciences Executive Sells Shares
Insider Transaction (Form 4)
David W. Boyer, Chief Corp. Affairs Officer of Neurocrine Biosciences Inc, sold 826 shares of common stock on September 11, 2026 for $157.45 per share.
Summary
- Grant/award: acquired 3,587 Common Stock on September 11, 2026; holds 11,484 after (Direct).
- Tax/exercise-price withholding: disposed of 1,936 Common Stock at $156.22 ($302,442) on September 11, 2026; holds 9,548 after (Direct).
- Open-market sale: disposed of 826 Common Stock at $157.45 ($130,051) on September 14, 2026; holds 8,722 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $130,051 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
David W. Boyer — Officer (Chief Corp. Affairs Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-11 | Grant/award | Common Stock | 3,587 | — | — | 11,484 |
| 2026-09-11 | Tax/exercise-price withholding | Common Stock | 1,936 | $156 | $302.4K | 9,548 |
| 2026-09-14 | Open-market sale | Common Stock | 826 | $157 | $130.1K | 8,722 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-11 | Grant/award (3,587 shares) |
| 2026-09-11 | Tax/exercise-price withholding (1,936 shares) |
| 2026-09-14 | Open-market sale (826 shares) |
Keywords
insider transaction, Form 4, NBIX, NEUROCRINE BIOSCIENCES INC, bearish, David W. Boyer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.